Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 492 for sleep

Edit search filters
  1. A Study Of The Gala Airway Treatment System For The Treatment Of Chronic Bronchitis In The United States

    Jacksonville, FL

  2. A Study To Assess The Safety, Tolerability And Effectiveness Of Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19

    Rochester, MN

  3. A Study To Evaluate The Efficacy And Safety Of Colchicine On Coronavirus SARS-CoV2 Positive Adults

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Phase 2 Safety And Efficacy Study Of Tulisokibart (MK-7240/PRA023) In Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

    Scottsdale/Phoenix, AZ

  5. A Study To Evaluate Agents To Treat Moderately Or Severely Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2

    Rochester, MN

  6. SenolyticsTreatment of Interstitial Lung Disease in Common Variable Immunodeficiency

    Rochester, MN

  7. A Phase 1 Proof-of-Concept Clinical Trial Evaluating the Safety and Tolerability of Midodrine in Hepatopulmonary Syndrome

    Rochester, MN

  8. A Dose Escalation Study Of Amivantamab In Participants With Advanced Non-Small Cell Lung Cancer

    Rochester, MN

  9. Abatacept For The Treatment Of Common Variable Immunodeficiency With Interstitial Lung Disease

    Rochester, MN

  10. Study Of Durvalumab + Tremelimumab With Chemotherapy Or Durvalumab With Chemotherapy Or Chemotherapy Alone For Patients With Lung Cancer (POSEIDON).

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer